Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 5,852 | 301 | N/A |
| Receivables | N/A | 38,028 | 28,755 | N/A |
| Inventories | N/A | 36,093 | 25,376 | N/A |
| Other current assets | 0 | 9,121 | 3,344 | 0 |
| TOTAL | $N/A | $89,094 | $57,776 | $N/A |
| Non-Current Assets | ||||
| PPE Net | N/A | 511,024 | 335,479 | N/A |
| Other Non-Current Assets | 0 | 11,579 | 13,854 | 0 |
| TOTAL | $N/A | $522,603 | $349,333 | $N/A |
| Total Assets | $N/A | $137,376 | $101,574 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | N/A | 3,792 | 16,836 | N/A |
| Accounts payable and accrued liabilities | 0 | 6,761 | 5,500 | 0 |
| Accrued Expenses | N/A | 15,139 | 11,742 | N/A |
| TOTAL | $N/A | $25,692 | $34,078 | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | 17,211 | 17,236 | N/A |
| TOTAL | $N/A | $21,391 | $19,098 | $N/A |
| Total Liabilities | $N/A | $47,083 | $53,176 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | N/A | 942 | 942 | N/A |
| Retained earnings | N/A | 68,514 | 26,808 | N/A |
| Other shareholders' equity | 0 | 602 | 413 | 0 |
| TOTAL | $N/A | $90,293 | $48,398 | $N/A |
| Total Liabilities And Equity | $0 | $137,376 | $101,574 | $0 |